Erythroderma/exfoliative dermatitis: A synopsis

International Journal of Dermatology

Volumn 43, Issue 1, 2004, Pages 39-47

  Sehgal, Virendra N ^a,b,c   Srivastava, Govind ^a,b,c   Sardana, Kabir ^a,b,c  

^a Sehgal Nursing Home   (India)

^b Behl Skin Institute   (India)

^c LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMINOSALICYLIC ACID DERIVATIVE; ARSENIC; BARBITURIC ACID DERIVATIVE; CAPTOPRIL; CHLOROQUINE; CIMETIDINE; DACTINOMYCIN; DAPSONE; GOLD; HYDANTOIN; HYDROXYZINE; INTERFERON; ISONIAZID; ISONICOTINIC ACID; ISOTRETINOIN; LITHIUM; MERCURY; METHOTREXATE; MINOCYCLINE; NITROFURANTOIN; OMEPRAZOLE; PARACETAMOL; PENICILLIN G; PHENOTHIAZINE; PHENYTOIN; RETINOID DERIVATIVE; STEROID; TRIAMCINOLONE ACETONIDE; UNINDEXED DRUG;

CLINICAL FEATURE; CONFERENCE PAPER; ERYTHRODERMA; EXFOLIATIVE DERMATITIS; HEMATOLOGIC MALIGNANCY; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; METABOLIC DISORDER; MORTALITY; PATHOGENESIS; PHOTOTHERAPY; PSORIASIS; PUVA; RETICULOENDOTHELIAL NEOPLASM;

DERMATITIS, EXFOLIATIVE; HUMANS; INCIDENCE; PROGNOSIS;

EID: 0842346842     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.01975.x     Document Type: Conference Paper

References (97)

1. Weismann K, Graham RM. Systemic disease and the skin. In: Champion RH, Burlain JL, Burns DA, et al., eds. Textbook of Dermatology, Vol. 3, 6th edn. Oxford: Blackwell Science, 1998: 2703-2758.
2. Borroas-Blasco J, Navarro-Ruiz A, Navarro-Blasco F, et al. Erythroderma induced by omeprazole. Int J Clin Pharmacol Ther 2001; 39: 219-223.
3. Holmes SA, Roberts DL. Erythroderma associated with St. John's Wort. Br J Dermatol 2000; 143: 1177-1178.
4. Rothe MJ, Bialy TL, Grantkals JM, et al. Dermatol Clin In: Champion RH, Burlain JL, Burns DA, et al., eds. 2000; 18: 405-415.
5. Friller DM, Milper MT, Briceland LL, et al. Frorafloxacin-associated exfoliative dermatitis in a homecare patient. Ann Pharmacother 1999; 33: 1122.
6. Ghura SH. Fatal erythroderma associated with pentostatin. Br Med J 1999; 28: 549.
7. Cockayne SE, Glet RJ, Gawkrodger DJ, et al. Severe erythroderma reactions to the proton pump inhibitors omeprazole and lansoprazole. Br J Dermatol 1999; 141: 173-175.
8. Karakayli G, Beckham G, Orengo T, et al. Exfoliative dermatitis. Am Fam Physician 1999; 59: 625-630.
9. Shelley WB, Shelley ED. Chronic erythroderma induced by beta-blocker (Timolol) eyedrops. J Am Acad Dermatol 1999; 37: 799-800.
10. Sigurdsson V, Toonstra J, Van Viotan WA. Idiopathic erythroderma - A follow-up study of 78 patients. Dermatology 1997; 194: 98-101.
11. Sigurdsson V, Toonstra J, Hazemanns-Boer M, et al. Erythroderma - A clinical and follow-up study of 102 patients with special emphasis on survival. J Am Acad Dermatol 1996; 35: 53-57.
12. Vascancellosc X, Damnigues PP, Aoki V, et al. Erythroderma - Analysis of 247 patients. Rav Sande Public 1995; 29: 177-182.
13. King LE Jr. Erythroderma. Who, where, when, why and how. Arch Dermatol 1994; 130: 1503-1507.
14. Botella-Estradas R, Sanmartin O, Oeiver V, et al. Erythroderma - A clinical pathological study of 56 cases. Arch Dermatol 1994; 130: 1503-1507.
15. Wilson DC, Jester JD, King LE Jr. Erythroderma, an exfoliative dermatitis. Clin Dermatol 1993; 11: 67-72.
16. Sehgal VN, Srivastava G. Exfoliative dermatitis - A prospective study of 80 patients. Dermatologica 1986; 173: 278-284.
17. Pruszkowski A, Bodemer C, Fraitay S, et al. Neonatal and infantile erythroderma - A retrospective study of 51 patients. Arch Dermatol 2000; 136: 875-880.
18. Sarkar R, Sharma RC, Koranne RV, et al. Erythroderma in children - A clinico-etiologic study. J Dermatol 1999; 26: 507-511.
19. Hoeger PH, Harper JI. Neonatal erythroderma: Differential diagnosis and management of 'red baby'. Arch Dis Child 1998; 79: 186-191.
20. Horn TD, Altomante V, Vofelsang G, et al. Erythroderma after autologous bone-marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer. J Am Acad Dermatol 1996; 34: 413-417.
21. Hisatomi K, Isomura T, Hirano A, et al. Post operative erythroderma after cardiac operation - Possible role for depressed cell-mediated immunity. J Thorac Cardiovasc Surg 1992; 107: 648-653.
22. Haga Y, Suma Y, Kawada K, et al. Two cases of post operative erythroderma. Keir J Med 1989; 38: 177-178.
23. Jenninger CK, Gaskan P, Schwartz RA, et al. Erythroderma as the initial presentation of AIDS. Dermatologica 1991; 183: 143-145.
24. Morar N, Dlova N, Gupta AK, et al. Erythroderma - A comparison between HIV positive and negative patients. Int J Dermatol 1999; 38: 859-900.
25. Smith KJ, Decker C, Yeager J, et al. Therapeutic efficacy of carbamazepine in HIV positive patient with psoriasis erythroderma. J Am Acad Dermatol 1997; 37: 851-854.
26. Abel EA, Lindee ML, Hoppe RT, et al. Benign and malignant forms of erythroderma. J Am Acad Dermatol 1988; 19: 1089-1095.
27. Wong KS, Wong SN, Jham SN, et al. Generalized exfoliative dermatitis: A clinical study of 108 patients. Ann Acad Med Singapore 1988; 17: 520-523.
28. Thestrup-Pederson K, Sorenson HC, Sogaard H, et al. The red man syndrome. Exfoliative dermatitis of unknown origin: A description and follow-up of 38 patients. J Am Acad Dermatol 1988; 18: 1307-1312.
29. Sigurdsson V, Steegmans PH, Van Vloten WA. Incidence of erythroderma - A survey among all dermatologists in the Netherlands. J Am Acad Dermatol 2001; 45: 675-678.
30. Pal S, Haroon TS. Erythroderma - A clinico-etiologic study of 90 patients. Int J Dermatol 1998; 37: 104-107.
31. Marks J. Erythroderma and its management. Clin Exp Dermatol 1982; 7: 415-422.
32. Hasan T, Jansen CT. Erythroderma - A follow-up of 50 patients. J Am Acad Dermatol 1989; 8: 836-840.
33. King LE Jr., Dufresne RG Jr., Lowelt GL, et al. Erythroderma - Review of 82 cases. South Med J 1986; 79: 1210-1215.
34. Binhlam JQ, King LE Jr. Erythroderma dermatitis. Dermatol Nurs 1994; 6: 323-330.
35. Leenufaphong V. Erythroderma in Thai patients. J Med Assoc Thai 1999; 82: 143-148.
36. Bojd AJ, Menter A. Erythrodermic psoriasis. J Am Acad Dermatol 1989; 21: 985-991.
37. Davies MG, Kersey PJ. Acute hepatitis and exfoliative dermatitits associated with minocycline. Br Med J 1989; 298: 1523-1524.
38. Raynolds NJ, Jones SK, Grossley J, et al. Exfoliative dermatitis due to nifedipine. Br J Dermatol 1989; 121: 401-404.
39. Denno K, Kume M, Ohta M, et al. Erythroderma with generalized lymphadenopathy induced by phenylosis. J Dermatol 1989; 16: 392-396.
40. Forrence EA, Goldman MP. Vancomycin-induced exfoliative dermatitis. DCIP 1990; 24: 369-371.
41. Fernandez DCL, Urrutia J, Audicana M, et al. Erythroderma after intravenous injection of methylprednisolone. Contact Dermatitis 1991; 25: 68-70.
42. Pajus I, Lestang P, Fiote O, et al. Erythroderma after clodronate treatment. Br Med J 1993; 307: 484.
43. Bielsa I. Erythroderma due to thalidomide: Report of 2 cases. Dermatology 1994; 189: 179-181.
44. Mohammed KN. Nifedipine induced exfoliative dermatitis and pedal edema. Ann Pharmacother 1994; 28: 967.
45. Odeh M. Exfoliative dermatitis associated with diltiazem. J Toxicol Clin Toxicol 1997; 35: 101-104.
46. Rebuck JA. Omeprazole induced exfoliative dermatitis. Pharmacotherapy 1998; 18: 877-879.
47. Hoziuchi Y. Propolis-induced erythroderma. J Dermatol 2001; 28: 580-581.
48. Sehgal VN, Rege VL. A retrospective study of exfoliative dermatitis. Indian J Dermatol Venereol 1974; 40: 36-39.
49. Nicolis GD, Helwig EB. Exfoliative dermatitis - A clinicopathologic study of 135 cases. Arch Dermatol 1973; 108: 787-797.
50. Abraham I, McGrathy JJ, Sanders SS. 101 cases of exfoliative dermatitis. Arch Dermatol 1963; 87: 96-101.
51. Wilson HTH. Exfoliative dermatitis, its etiology and prognosis. Arch Dermatol 1954; 69: 577-588.
52. Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythroderma cutaneous T-cell lymphoma - Report of International Society for Cutaneous Lymphoma. J Am Acad Dermatol 2002; 46: 95-106.
53. Patrizi A, Pileri S, Rivano MT, et al. Malignant histiocytosis presenting as erythroderma. Int J Dermatol 1990; 29: 214-216.
54. Rosen T, Choppel R, Drucker C. Exfoliative dermatitis - Presenting symptom of internal malignancy. South Med J 1979; 72: 652-653.
55. Axelrod JH, Herbold DR, Fred JH, et al. Exfoliative dermatitis - Presenting symptom of fallopian tube carcinoma. Obstet Gynaecol 1988; 71: 1045-1047.
56. Faure M, Bertrand C, Manduit G, et al. Panneoplastic erythroderma - Apropos of a case. Dermatologica 1985; 170: 147-151.
57. Deffer TA, Keary PPO, Goette DK. Erythroderma secondary to oesophageal carcinoma. J Am Acad Dermatol 1985; 13: 311-312.
58. Camacho FM, Garcia-Hernandez MJ, Munoz-Perez MA, et al. Ofuji-papuloerythroderma in an elderly woman with atopic erythroderma. J Eur Acad Dermatol Venereol 2001; 15: 264-266.
59. Satoli H, Yamashita YT, Ohtsuka J, et al. Post irradiation erythroderma. Clin Oncol 2000; 12: 336.
60. Astei N, Fumo G, Conti B, et al. Ofuji papuloerythroderma. J Eur Acad Dermatol Venereol 2000; 14: 55-57.
61. Lowenthal RM, Challis DR, Griffiths AE, et al. Transfusion associated graft-versus-host disease. Transfusion 1993; 33: 524-529.
62. Hild DH. Folate loss from the skin in exfoliative dermatitis. Arch Intern Med 1969; 123: 51-57.
63. Freeberg IM. Exfoliative dermatitis. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al., eds. Dermatology in General Medicine, 4th edn. New York: McGraw-Hill, 1993: 527-530.
64. Sigurdsson V, Toonstra J, Bihari IC, et al. Interleukin-4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides - An immunohistochemical study. J Cutan Pathol 2002; 27: 429-435.
65. Sigurdsson V, De Vries IJ, Toonstra J, et al. Expression of VCAM-I, ICAM-I, E-selectin and P-selectin on endothelium in situ in patients with erythroderma mycosis fungoides and atopic dermatitis. J Cutan Pathol 2000; 27: 436-440.
66. Frenk E, Gueissaz F, Vion B. Senile erythroderma with hyper IgE. Dermatologica 1991; 183: 72-73.
67. Gupta R, Khera V. Erythroderma due to dermatophyte. Acta Derm Venereol 2001; 81: 70.
68. Nousari HC, Moresi M, Klapper M, et al. Non-endemic pemphigus foliaceus presenting as fatal bullous exfoliative erythroderma. Cutis 2001; 67: 251-252.
69. Kunz M, Wilheln S, Freund M, et al. Treatment of severe erythrodermic acute graft-versus-host disease with photochemotherapy. Br J Dermatol 2001; 144: 901-902.
70. Hidano A, Yamashita N, Mizuguchi M, et al. Clinical, histological and immunohistological studies in post operative erythroderma. J Dermatol 1989; 16: 20-30.
71. Sadick NS, McNutt NS, Kaplan MH. Papulosquamous dermatoses of AIDS. J Am Acad Dermatol 1990; 22: 1270-1277.
72. Grice KA, Bettley FR. Skin water loss and accidental hypothermia in psoriasis, ichthyosis and erythroderma. Br Med J 1967; 4: 195-198.
73. Shuster S, Wilkinson P. Protein metabolism in exfoliative dermatitis and erythroderma. Br J Dermatol 1963; 75: 344-346.
74. Fox RH. Cardiovascular, metabolic and thermo-regulatory disorders in patients with erythrodermic skin disease. Br Med J 1965; 1: 619-622.
75. Voight GC, Kronthol HI, Lrounse RG. Cardiac output in erythrodermic skin disease. Am Heart J 1966; 72: 615-620.
76. Walsh NM, Prokopetz R, Tron VA, et al. Histopathology in erythroderma - Review of a series of cases by multiple observers. J Cutan Pathol 1994; 71: 419-423.
77. Zip C, Murray S, Walsh NM. The specificity of histopathology in erythroderma. J Cutan Pathol 1993; 20: 393-394.
78. Levine N. Exfoliative dermatitis - Skin biopsy is required to determine the cause of this pruritic eruption. Geriatrcs 2000; 55: 25.
79. Tomasini C, Aloi F, Solaroli C, et al. Psoriatic erythroderma - A histopathologic study of 45 patients. Dermatology 1997; 194: 102-106.
80. Patterson JW, Berry AD 3rd, Darwin BS, et al. Lichenoid histopathologic changes in patients with clinical diagnosis of exfoliative dermatitis. Am J Dermatopathol 1991; 13: 358-364.
81. Sentis HJ, Wallemze R, Scheffer E. Histopathologic studies in Sezary's syndrome and erythroderma mycosis fungoides: A comparison with benign forms of erythroderma. J Am Acad Dermatol 1986; 15: 1217-1226.
82. 4+T lymphocytopenia. Arch Dermatol 1994; 130: 1530.
83. Iyer VK, Kopile K, Verma K. FNAC of dermatopathic lymphadenitis. Acta Cytol 1998; 42: 1347-1351.
84. Charry S, Mraz S, Su L, et al. Heteroduplex analysis of T-cell receptors gamma gene re-arrangement as an adjuvant tool in diagnosis in skin biopsies from erythroderma. J Cutan Pathol 2001; 28: 351-355.
85. Anonymous. Management of erythrodermic psoriasis with low dose cyclosporine - SIMPSO. Dermatology 1993; 187: 30-37.
86. Smith KJ, Skelton HG. Accidental success of carbamazepine for psoriatic erythroderma. N Engl J Med 1996; 26: 1999-2000.
87. Blin O, Sangla J, Serratrice G. Delayed carbamazepine-induced exfoliative dermatitis. Therapies 1991; 46: 91.
88. Okuyama R. Carbamazepine induced erythroderma with systemic lymphadenopathy. J Dermatol 1996; 23: 489-494.
89. Troost RJ, Oranje AP, Lijnen RL, et al. Exfoliative dermatitis due to immunologically confirmed carbamazepine hypersensitivity. Pediatr Dermatol 1996; 13: 316-320.
90. Peters T. Exfoliative dermatitis after long-term methotrexate treatment for severe psoriasis. Acta Dermatol Venereol 1999; 79: 391-392.
91. Sommer S, Henderson CA. Papuloerythroderma of Ofuji responding to treatment with cyclosporine. Clin Exp Dermatol 2000; 25: 293-295.
92. Fussel-Jones R, Whittaker S. Sezary syndrome - Diagnostic criteria and therapeutic options. Semin Cutan Med Surg 2000; 19: 100-108.
93. Rosen T. Exfoliative dermatitis. In: Maddin S, Carruthers A, Brown TH, eds. Current Dermatologic Therapy. Philadelphia: Saunders, 1982: 169-170.
94. Shelley WB, Shelley ED. Erythroderma. In: Shelley WB, Shelley ED, eds. Advanced Dermatologic Therapy. Philadelphia: Saunders, 1987: 185-189.
95. Mogavera HS. Exfoliative dermatitis. In: Provost TT, Farmer ER, eds. Current Therapy in Dermatology, 2nd edn. Philadelphia: Dekker, 1988: 20-21.
96. Schwartz RA, Trotter MG. Generalized vitiligo after erythroderma. Dermatologica 1983; 167: 42-46.
97. Torres JE, Sanchez JL. Disseminated pyogenic granuloma developing after an exfoliative dermatitis. J Am Acad Dermatol 1995; 32: 280-282.